About two-thirds of the women had a pathogenic variant in BRCA1 and one-third had a pathogenic variant in BRCA2. Almost half of the women had a previous cancer diagnosis (86.1% breast cancer and 15.8% OC). This evidence concerns the gene BRCA2 and cancer.